Sodium Sulfacetamide And Sulfur Suspension
Product Images NDC 44523-624

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Sulfacetamide And Sulfur (NDC 44523-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocomp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Sodium Sulfacetamide 8 And Sulfur 4 Suspension Formula)

Chemical structure of sulfacetamide sodium, an active ingredient in the topical suspension product Sodium Sulfacetamide and Sulfur by BioComp Pharma, Inc.*

FDA Label Image

Label (Sodium Sulfacetamide 8 And Sulfur 4 Suspension Label)

Four pages of detailed prescribing information for SODIUM SULFACETAMIDE 8% AND SULFUR 4% Suspension, a topical drug by BioComp Pharma, Inc. The label includes dosage and administration instructions, storage conditions, adverse reactions, contraindications, clinical pharmacology, warnings, precautions, and patient information including pregnancy and pediatric use warnings. The product is supplied in 16 oz (473 mL) bottles and is Rx only.*

FDA Label Image

Image (Sodium Sulfacetamide 8 And Sulfur 4 Suspension Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.